BR9206072A - Combinations of calcium, trace minerals, vitamin D and drug therapies. - Google Patents

Combinations of calcium, trace minerals, vitamin D and drug therapies.

Info

Publication number
BR9206072A
BR9206072A BR9206072A BR9206072A BR9206072A BR 9206072 A BR9206072 A BR 9206072A BR 9206072 A BR9206072 A BR 9206072A BR 9206072 A BR9206072 A BR 9206072A BR 9206072 A BR9206072 A BR 9206072A
Authority
BR
Brazil
Prior art keywords
vitamin
calcium
combinations
drug therapies
trace minerals
Prior art date
Application number
BR9206072A
Other languages
Portuguese (pt)
Inventor
Mark Benson Andon
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9206072A publication Critical patent/BR9206072A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9206072A 1991-05-28 1992-05-15 Combinations of calcium, trace minerals, vitamin D and drug therapies. BR9206072A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70583291A 1991-05-28 1991-05-28
PCT/US1992/003995 WO1992021355A1 (en) 1991-05-28 1992-05-15 Calcium, trace mineral, vitamin d and drug therapy combinations

Publications (1)

Publication Number Publication Date
BR9206072A true BR9206072A (en) 1994-11-15

Family

ID=24835140

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9206072A BR9206072A (en) 1991-05-28 1992-05-15 Combinations of calcium, trace minerals, vitamin D and drug therapies.

Country Status (13)

Country Link
EP (1) EP0586521A1 (en)
JP (1) JPH07502012A (en)
KR (1) KR100244603B1 (en)
AU (1) AU666654B2 (en)
BR (1) BR9206072A (en)
CA (1) CA2109958C (en)
CZ (1) CZ281823B6 (en)
HU (1) HUT66379A (en)
IE (1) IE921701A1 (en)
NO (1) NO934282L (en)
NZ (1) NZ242920A (en)
SK (1) SK132693A3 (en)
WO (1) WO1992021355A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
FR2704393B1 (en) * 1993-04-30 1995-06-02 Boiron Absorbable nutritional supplement to optimize growth and maintain strong bones.
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
FR2723682B1 (en) * 1994-08-19 1996-09-27 Boiron ABSORBABLE NUTRITIONAL SUPPLEMENT FOR THE DAILY BALANCE OF CHILDREN AND ADOLESCENTS.
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
DE19503190A1 (en) * 1995-02-01 1996-08-08 Dietl Hans Means for influencing disorders of bone formation
US5597595A (en) * 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5698222A (en) * 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
US5609897A (en) * 1995-04-07 1997-03-11 Abbott Laboratories Powdered beverage concentrate or additive fortified with calcium and vitamin D
CA2266098A1 (en) * 1996-09-26 1998-04-02 Oklahoma Medical Research Foundation Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
KR20000071039A (en) * 1997-02-13 2000-11-25 비숍 찰스 더블유. Targeted therapeutic delivery of vitamin D compounds
GB9703109D0 (en) * 1997-02-14 1997-04-02 Smith & Nephew Compositions
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
PT2266584E (en) * 2003-05-07 2012-12-19 Osteologix As Composition with strontium and vitamin d for the prophylaxis and/or treatment of cartilage and/or bone conditions
WO2005072539A1 (en) * 2004-01-28 2005-08-11 Dr. Paul Lohmann Gmbh Kg Method for the production of a calcium lactate malate compound and calcium lactate malate compound
AU2005275193A1 (en) * 2004-07-15 2006-02-23 Nanobac Life Sciences Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
AU2007217851A1 (en) * 2006-02-21 2007-08-30 Nutrijoy, Inc. Food and beverage products with improved taste impressions
JP5619334B2 (en) * 2006-06-14 2014-11-05 允聖 崔 Bone strengthening agent
US7504536B2 (en) 2006-08-17 2009-03-17 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
AU2007285386B2 (en) * 2006-08-17 2011-02-03 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
WO2009019307A2 (en) * 2007-08-09 2009-02-12 Novartis Ag Oral calcitonin compositions and applications thereof
US9867838B2 (en) 2009-09-01 2018-01-16 Duke University Methods for treating heart failure using bisphosphonate compositions
CN104010647A (en) 2011-11-16 2014-08-27 杜克大学 Bishophonate compositions and methods for treating and/or reducing cardiac dysfunction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992556A (en) * 1973-05-07 1976-11-16 Vitamins, Inc. Supplemented food product
GB8622025D0 (en) * 1986-09-12 1986-10-22 Beecham Group Plc Composition
FR2618305B1 (en) * 1987-07-23 1989-10-27 Synthelabo NUTRITIONAL MIXTURE FOR THE ELDERLY
JP2516794B2 (en) * 1988-02-26 1996-07-24 雪印乳業株式会社 Baby formula containing vitamin D metabolites
EP0343703A3 (en) * 1988-05-26 1990-06-06 The Procter & Gamble Company Mineral supplements with sugar alcohols
US5151274A (en) * 1990-08-06 1992-09-29 The Procter & Gamble Company Calcium and trace mineral supplements

Also Published As

Publication number Publication date
CA2109958C (en) 1997-06-10
NZ242920A (en) 1995-06-27
CZ281823B6 (en) 1997-02-12
EP0586521A1 (en) 1994-03-16
NO934282L (en) 1994-01-28
KR100244603B1 (en) 2000-03-02
AU666654B2 (en) 1996-02-22
AU1996892A (en) 1993-01-08
NO934282D0 (en) 1993-11-26
HUT66379A (en) 1994-11-28
JPH07502012A (en) 1995-03-02
SK132693A3 (en) 1994-06-08
HU9303364D0 (en) 1994-03-28
CZ255393A3 (en) 1994-07-13
WO1992021355A1 (en) 1992-12-10
IE921701A1 (en) 1992-12-02

Similar Documents

Publication Publication Date Title
BR9206072A (en) Combinations of calcium, trace minerals, vitamin D and drug therapies.
TR27288A (en) Vitamin and mineral supplements.
FI893340A (en) FOERFARANDE FOER ATT ERHAOLLA PHARMACEUTICAL SAMMANSAETTNINGAR FOER ATT HINDRA SMITTBARA KOENSSJUKDOMAR.
DE68921798D1 (en) Therapeutic nuleosides.
FI903656A0 (en) THERAPEUTIC KINUCLIDIN INFOERING.
NL300047I1 (en) Pharmaceutical composition.
FI903823A0 (en) SOEMSTRUKTUR VID EN PRODUKT ANVAENDBAR I PAPPERSTILLVERKNINGEN.
DE3885731D1 (en) Bone screw.
NL300045I2 (en) Fluorcytidine derivatives, their preparation and drugs containing these derivatives.
FI894688A (en) FLYTANDE ORALT TAGBART THERAPEUTIC SYSTEM.
NO882653D0 (en) DOSAGE FORM.
MX9201154A (en) NOVELTY DERIVATIVES OF 2-CARBOXYINDOLES THAT HAVE PHARMACEUTICAL ACTIVITY.
FI893643A (en) PHARMACEUTICAL COMPOSITION.
DE68906345D1 (en) ANTIMALARIA COMPILATIONS USING QUINIDIN, ARTEMISININ AND THEIR DERIVATIVES.
DE68907536D1 (en) STABILIZED VITAMIN POWDER.
DE68907177D1 (en) DOSAGE FORM.
FI893897A (en) THERAPEUTIC NUCLEOSIDER.
FI901876A0 (en) OFULLSTAENDIGA HEPADNAVIRUS, VACCIN PRODUCERANDE CELLINJER SAMT THERAPY AV LEVERSJUKDOMAR.
NO903217D0 (en) PLOW.
DE68924369D1 (en) Microprocessor system.
FI894321A0 (en) THERAPEUTIC AEMNEN.
ES1006941Y (en) PETANCA BALL.
DE69012950D1 (en) Anti-cancer drugs.
NO890988D0 (en) DISUBSTITUTED PYROLES.
FI891544A0 (en) TRANSPORTATION OF MEDICINES.

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal